🔎 Trials Near Me

Akèy › Leukemi limfoblastik ak limfom selil T prekursè › Texas › Houston

Etid klinik pou Leukemi limfoblastik ak limfom selil T prekursè nan Houston, TX

8 etid pou Leukemi limfoblastik ak limfom selil T prekursè ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Ap rekriteFaz 2
  • MD Anderson Cancer Center, Houston
6 Months · Tout sèks · Mizajou Sep 28, 2026 · NCT06514794

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

Ap rekriteFaz 1
  • MD Anderson Cancer Center, Houston
Jiska laj 39 · Tout sèks · Mizajou Sep 11, 2026 · NCT04972942

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

Ap rekriteFaz 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Jiska laj 75 · Tout sèks · Mizajou Aug 11, 2026 · NCT03081910

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Ap rekriteFaz 2
  • M D Anderson Cancer Center, Houston
Tout laj · Tout sèks · Mizajou Jul 15, 2026 · NCT00501826

A Registry for People With T-cell Lymphoma

Ap rekriteEtid obsèvasyon
  • MD Anderson Cancer Center (Data Collection Only), Houston
Tout laj · Tout sèks · Mizajou May 20, 2026 · NCT05978141

Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells

Ap rekriteFaz 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Jiska laj 75 · Tout sèks · Mizajou May 18, 2026 · NCT07220993

Etid Leukemi limfoblastik ak limfom selil T prekursè nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.